Cargando…

Machine Learning and Radiogenomics: Lessons Learned and Future Directions

Due to the rapid increase in the availability of patient data, there is significant interest in precision medicine that could facilitate the development of a personalized treatment plan for each patient on an individual basis. Radiation oncology is particularly suited for predictive machine learning...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, John, Rancati, Tiziana, Lee, Sangkyu, Oh, Jung Hun, Kerns, Sarah L., Scott, Jacob G., Schwartz, Russell, Kim, Seyoung, Rosenstein, Barry S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021505/
https://www.ncbi.nlm.nih.gov/pubmed/29977864
http://dx.doi.org/10.3389/fonc.2018.00228
_version_ 1783335487134498816
author Kang, John
Rancati, Tiziana
Lee, Sangkyu
Oh, Jung Hun
Kerns, Sarah L.
Scott, Jacob G.
Schwartz, Russell
Kim, Seyoung
Rosenstein, Barry S.
author_facet Kang, John
Rancati, Tiziana
Lee, Sangkyu
Oh, Jung Hun
Kerns, Sarah L.
Scott, Jacob G.
Schwartz, Russell
Kim, Seyoung
Rosenstein, Barry S.
author_sort Kang, John
collection PubMed
description Due to the rapid increase in the availability of patient data, there is significant interest in precision medicine that could facilitate the development of a personalized treatment plan for each patient on an individual basis. Radiation oncology is particularly suited for predictive machine learning (ML) models due to the enormous amount of diagnostic data used as input and therapeutic data generated as output. An emerging field in precision radiation oncology that can take advantage of ML approaches is radiogenomics, which is the study of the impact of genomic variations on the sensitivity of normal and tumor tissue to radiation. Currently, patients undergoing radiotherapy are treated using uniform dose constraints specific to the tumor and surrounding normal tissues. This is suboptimal in many ways. First, the dose that can be delivered to the target volume may be insufficient for control but is constrained by the surrounding normal tissue, as dose escalation can lead to significant morbidity and rare. Second, two patients with nearly identical dose distributions can have substantially different acute and late toxicities, resulting in lengthy treatment breaks and suboptimal control, or chronic morbidities leading to poor quality of life. Despite significant advances in radiogenomics, the magnitude of the genetic contribution to radiation response far exceeds our current understanding of individual risk variants. In the field of genomics, ML methods are being used to extract harder-to-detect knowledge, but these methods have yet to fully penetrate radiogenomics. Hence, the goal of this publication is to provide an overview of ML as it applies to radiogenomics. We begin with a brief history of radiogenomics and its relationship to precision medicine. We then introduce ML and compare it to statistical hypothesis testing to reflect on shared lessons and to avoid common pitfalls. Current ML approaches to genome-wide association studies are examined. The application of ML specifically to radiogenomics is next presented. We end with important lessons for the proper integration of ML into radiogenomics.
format Online
Article
Text
id pubmed-6021505
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60215052018-07-05 Machine Learning and Radiogenomics: Lessons Learned and Future Directions Kang, John Rancati, Tiziana Lee, Sangkyu Oh, Jung Hun Kerns, Sarah L. Scott, Jacob G. Schwartz, Russell Kim, Seyoung Rosenstein, Barry S. Front Oncol Oncology Due to the rapid increase in the availability of patient data, there is significant interest in precision medicine that could facilitate the development of a personalized treatment plan for each patient on an individual basis. Radiation oncology is particularly suited for predictive machine learning (ML) models due to the enormous amount of diagnostic data used as input and therapeutic data generated as output. An emerging field in precision radiation oncology that can take advantage of ML approaches is radiogenomics, which is the study of the impact of genomic variations on the sensitivity of normal and tumor tissue to radiation. Currently, patients undergoing radiotherapy are treated using uniform dose constraints specific to the tumor and surrounding normal tissues. This is suboptimal in many ways. First, the dose that can be delivered to the target volume may be insufficient for control but is constrained by the surrounding normal tissue, as dose escalation can lead to significant morbidity and rare. Second, two patients with nearly identical dose distributions can have substantially different acute and late toxicities, resulting in lengthy treatment breaks and suboptimal control, or chronic morbidities leading to poor quality of life. Despite significant advances in radiogenomics, the magnitude of the genetic contribution to radiation response far exceeds our current understanding of individual risk variants. In the field of genomics, ML methods are being used to extract harder-to-detect knowledge, but these methods have yet to fully penetrate radiogenomics. Hence, the goal of this publication is to provide an overview of ML as it applies to radiogenomics. We begin with a brief history of radiogenomics and its relationship to precision medicine. We then introduce ML and compare it to statistical hypothesis testing to reflect on shared lessons and to avoid common pitfalls. Current ML approaches to genome-wide association studies are examined. The application of ML specifically to radiogenomics is next presented. We end with important lessons for the proper integration of ML into radiogenomics. Frontiers Media S.A. 2018-06-21 /pmc/articles/PMC6021505/ /pubmed/29977864 http://dx.doi.org/10.3389/fonc.2018.00228 Text en Copyright © 2018 Kang, Rancati, Lee, Oh, Kerns, Scott, Schwartz, Kim and Rosenstein. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Kang, John
Rancati, Tiziana
Lee, Sangkyu
Oh, Jung Hun
Kerns, Sarah L.
Scott, Jacob G.
Schwartz, Russell
Kim, Seyoung
Rosenstein, Barry S.
Machine Learning and Radiogenomics: Lessons Learned and Future Directions
title Machine Learning and Radiogenomics: Lessons Learned and Future Directions
title_full Machine Learning and Radiogenomics: Lessons Learned and Future Directions
title_fullStr Machine Learning and Radiogenomics: Lessons Learned and Future Directions
title_full_unstemmed Machine Learning and Radiogenomics: Lessons Learned and Future Directions
title_short Machine Learning and Radiogenomics: Lessons Learned and Future Directions
title_sort machine learning and radiogenomics: lessons learned and future directions
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021505/
https://www.ncbi.nlm.nih.gov/pubmed/29977864
http://dx.doi.org/10.3389/fonc.2018.00228
work_keys_str_mv AT kangjohn machinelearningandradiogenomicslessonslearnedandfuturedirections
AT rancatitiziana machinelearningandradiogenomicslessonslearnedandfuturedirections
AT leesangkyu machinelearningandradiogenomicslessonslearnedandfuturedirections
AT ohjunghun machinelearningandradiogenomicslessonslearnedandfuturedirections
AT kernssarahl machinelearningandradiogenomicslessonslearnedandfuturedirections
AT scottjacobg machinelearningandradiogenomicslessonslearnedandfuturedirections
AT schwartzrussell machinelearningandradiogenomicslessonslearnedandfuturedirections
AT kimseyoung machinelearningandradiogenomicslessonslearnedandfuturedirections
AT rosensteinbarrys machinelearningandradiogenomicslessonslearnedandfuturedirections